Mirvie is a series b startup based in United States. 1 investor tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
Mirvie is developing a blood test to predict pregnancy complications like preeclampsia, preterm birth, and gestational diabetes by analyzing RNA from the mother, baby, and placenta.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky